JPS6363374A - Novel bacillus sp h1402 - Google Patents
Novel bacillus sp h1402Info
- Publication number
- JPS6363374A JPS6363374A JP20515386A JP20515386A JPS6363374A JP S6363374 A JPS6363374 A JP S6363374A JP 20515386 A JP20515386 A JP 20515386A JP 20515386 A JP20515386 A JP 20515386A JP S6363374 A JPS6363374 A JP S6363374A
- Authority
- JP
- Japan
- Prior art keywords
- bacillus
- protein
- formation
- test
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 title abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 26
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 25
- 108091005804 Peptidases Proteins 0.000 claims abstract description 11
- 102000035195 Peptidases Human genes 0.000 claims description 10
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 9
- 238000012360 testing method Methods 0.000 abstract description 5
- 230000000877 morphologic effect Effects 0.000 abstract description 3
- 239000004365 Protease Substances 0.000 abstract description 2
- 230000001766 physiological effect Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- 102000016938 Catalase Human genes 0.000 abstract 1
- 108010053835 Catalase Proteins 0.000 abstract 1
- 229910002651 NO3 Inorganic materials 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 108010046334 Urease Proteins 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 210000003495 flagella Anatomy 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 24
- 230000001580 bacterial effect Effects 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 239000002609 medium Substances 0.000 description 8
- 102000011632 Caseins Human genes 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000012770 industrial material Substances 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000009727 food gelling agent Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、新規なバチルス・sp H1402に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel Bacillus sp H1402.
従来、一般に蛋白質を微生物によって生産させるという
場合、微生物を培養し、微生物菌体を磨砕後、蛋白質を
抽出、精製することにより得ていた。Conventionally, when proteins were produced by microorganisms, they were generally obtained by culturing the microorganisms, grinding the microbial cells, and then extracting and purifying the proteins.
また、一般に遺伝子組換えの微生物生産の宿主としては
、大腸菌が主に使用されているが、大腸菌では、組換え
遺伝子によって合成されるペプチドや蛋白質は細胞内に
とどまり培地中に分泌生産されないため、自づとその生
産量は制限されていた。In addition, Escherichia coli is generally used as a host for genetically modified microorganism production, but in Escherichia coli, the peptides and proteins synthesized by recombinant genes remain within the cells and are not secreted into the culture medium. Naturally, its production was limited.
しかし、細胞磨砕によりペプチド、蛋白質を抽出精製す
ることは、操作が煩雑になるなどの欠点が指摘されてい
る。However, it has been pointed out that extracting and purifying peptides and proteins by cell grinding has drawbacks such as complicated operations.
鵜高は、先に、遺伝子組換えにおける宿主菌として蛋白
質を菌体外に分泌する微生物を求めて研究した結果、蛋
白質を多量に分泌生産する微生物として、約1200株
のなかからバチルス・プレビス(Bacillus b
revis) 4株、新菌株バチルス−プロテア−マン
ス(Bacillus proteiformans)
1株の5株を分離同定するに至った。(Agric、
Biol。Udaka had previously researched microorganisms that secrete proteins outside of their cells as host bacteria for genetic recombination, and as a result, selected Bacillus plebis (Bacillus plebis) from among about 1,200 strains as microorganisms that secrete and produce large amounts of proteins. Bacillus b
revis) 4 strains, new strain Bacillus proteiformans (Bacillus proteiformans)
We were able to isolate and identify 5 strains of 1 strain. (Agric,
Biol.
Chew、、 40(3)、 523−528(197
6))また、一方、分泌宿主−ベクターとして枯草菌も
利用され、α−アミラーゼ、インターフェロンなど各種
異種蛋白質を培地中に蓄積させることに成功しているが
、菌体内外の強いプロテアーゼにより生産量が制限され
たり、分解されたりして、良好な結果は得られていない
。Chew, 40(3), 523-528 (197
6)) On the other hand, Bacillus subtilis has also been used as a secretion host-vector and has been successful in accumulating various heterologous proteins such as α-amylase and interferon in the culture medium, but the production volume is limited due to strong proteases inside and outside the bacterial body. are limited or degraded, and good results have not been achieved.
先に、鵜高らは、バチルス・ステアロサーモフィルス(
Bacillus stearothermophil
us)DY−5の耐熱性α−アミラーゼ遺伝子をプラス
ミドptiB110に組込んだpBAMlolを保有す
るバチルス・プレビス47及び枯草菌を37℃、48時
間培養した時、バチルス・プレビス47では約15,0
OOU/mu、枯草菌では3.0000/mQ程度のα
−アミラーゼをそれぞれ培地中に生産蓄積するのを確認
した。(J 、 Bacteriol 、 。Previously, Udaka et al.
Bacillus stearothermophil
us) When Bacillus plevis 47 and Bacillus subtilis carrying pBAMlol, in which the thermostable α-amylase gene of DY-5 was integrated into plasmid ptiB110, and Bacillus subtilis were cultured at 37°C for 48 hours, Bacillus plevis 47 exhibited approximately 15.0
OOU/mu, α of about 3.0000/mQ for Bacillus subtilis
- It was confirmed that amylase was produced and accumulated in the culture medium. (J. Bacteriol.
164、(3)、 1182−1187(1985))
。164, (3), 1182-1187 (1985))
.
ここに、全く同一のプラスミドを保有するバチルス・プ
レビス47(後述)と枯草菌とでは、耐熱性α−アミラ
ーゼの生産においてバチルス・プレビス47の方が約5
倍も生産効率のよいという事実から蛋白質生産菌の有す
る蛋白質分泌能を用いることにより異種遺伝子産物を効
率良く分泌生産させうろことが判明した。Here, between Bacillus plevis 47 (described later) and Bacillus subtilis, which carry exactly the same plasmid, Bacillus plevis 47 is approximately 5 times more efficient in producing heat-stable α-amylase.
The fact that the production efficiency is twice as high indicates that a heterologous gene product can be efficiently secreted and produced by using the protein secretion ability of protein-producing bacteria.
しかしながら、先に蛋白質を多量に菌体外に分泌生産す
る細菌として分離同定したバチルス・プレビス47.1
44.481.899、バチルス・プロテイホーマンス
444の5株は、いずれも培地中に牛血清アルブミン(
以下BSAという。)を添加して生育させるとBSAを
分解し、更にバチルス・プレビス144゜481、89
9、及びバチルス・プロテイホーマンス444の4株は
カゼイン分解活性も有していることが確認された。従っ
て、これら蛋白質を多量に菌体外に分泌生産する細菌を
宿主として組換え遺伝子によって異種遺伝子産物を分泌
生産させる時、効率良く分泌生産されたペプチド、蛋白
質が蛋白質分解酵素によって分解されると考えられた。However, Bacillus plevis 47.1, which was previously isolated and identified as a bacterium that secretes and produces large amounts of protein outside the bacterial body.
44.481.899 and Bacillus proteihomans 444, all of which contained bovine serum albumin (
Hereinafter referred to as BSA. ), it decomposes BSA and further increases Bacillus plebis 144゜481, 89.
It was confirmed that four strains of B. 9 and Bacillus proteihomans 444 also had casein-degrading activity. Therefore, when we secrete and produce heterologous gene products using recombinant genes using bacteria that secrete and produce large amounts of these proteins outside the bacterial body, we believe that the secreted and produced peptides and proteins will be efficiently degraded by proteolytic enzymes. It was done.
そこで1本発明者らは、蛋白質を著量分泌し。Therefore, the present inventors secreted a significant amount of protein.
かつ、蛋白質分解酵素を菌体外に全く生産しない菌株が
見い比されれば、遺伝子組換えにおける宿主菌としてす
ぐれたものであるとの発想から、このような菌株を求め
て鋭意選別を行ったところ、各種試料から分離した約1
00,000株のなかから。In addition, if we can find a strain that does not produce any proteolytic enzymes outside the bacterial body, we believe that it would be an excellent host for genetic recombination, so we carried out intensive selection in search of such strains. As a result, approximately 1
Out of 00,000 shares.
菌体外に著量の蛋白質を生産するが、蛋白質分解酵素を
菌体外に生産しない株を単離することに成功したのであ
る。They succeeded in isolating a strain that produces a significant amount of protein extracellularly, but does not produce proteolytic enzymes extracellularly.
ここに単離された株について、種の同定を行ったところ
、バチルスに属すものと同定され1本発明を完成するに
到った。When the strain isolated here was identified as belonging to Bacillus, the present invention was completed.
本発明は、菌体外に著量の蛋白質を生産するが。The present invention produces a significant amount of protein outside the bacterial cells.
蛋白質分解酵素を生産しないバチルス・sp H140
2である。Bacillus sp H140 that does not produce proteolytic enzymes
It is 2.
従来、バチルス属において、蛋白質を生産する菌株は知
られているが、周知の菌株はすべて蛋白質分解酵素を生
産するものであって、本発明の、菌体外に著量の蛋白質
を生産するが、蛋白質分解酵素を菌体外に生産しないバ
チルス・sp H1402は全く知られておらず、新規
である。Conventionally, strains of Bacillus that produce protein have been known, but all of the known strains produce proteolytic enzymes, and the present invention, which produces a significant amount of protein outside the bacterial body, Bacillus sp H1402, which does not produce proteolytic enzymes outside its cells, is completely unknown and is new.
本発明においては、蛋白質を5g#1以上培地中に分泌
生産しかつBSA、カゼインのいずれの蛋白質をも分解
しない菌株を目標に選択分離された。In the present invention, strains that secrete and produce 5 g or more of protein into the medium and do not degrade either BSA or casein proteins were selected and isolated.
まず、土壌などの試料から分離された約100.000
株の菌株をT2寒天平板培地(1%グルコース、1%ペ
プトン、0.5%肉エキス、0.2%酵母エキス、1.
5%寒天末、pH7,0)に接種し、平板培地上でコロ
ニー周辺が5%過塩素酸に白濁する細菌を選択した。次
に、ここに分離した細菌株をT2液体培地(150mQ
容三角フラスコ、培地量10社)で振盪培養(30℃、
48時間)し、その培養濾液中に1.2gIQ以上の蛋
白質を生産する菌株を80株得た。First, approximately 100,000
strains were grown on T2 agar plates (1% glucose, 1% peptone, 0.5% meat extract, 0.2% yeast extract, 1.
The bacteria were inoculated onto 5% agar powder, pH 7.0), and bacteria whose periphery became cloudy with 5% perchloric acid were selected on a plate medium. Next, the bacterial strain isolated here was transferred to a T2 liquid medium (150 mQ
Culture with shaking (30°C,
48 hours), and 80 strains producing 1.2 g IQ or more of protein in the culture filtrate were obtained.
菌体外蛋白質の測定においては、培養液に等量の0.2
N NaOHを加え攪拌後10,000rpmX 5分
遠心分離処理して菌体を除き、上清に等量の10%トリ
クロル酢酸を加えて10分後3,000rpa+ X
10分間遠心分離して沈殿を集め、IN NaOHで溶
解したのちLowry法(J、 Biol、 Chem
、 193.265(1951)3によって定量し、蛋
白質量は牛血清アルブミンとして換算した。 蛋白質高
生産培地として第1表に示す培地を選んだ。When measuring extracellular proteins, add an equal amount of 0.2
Add N NaOH, stir, and centrifuge at 10,000 rpm for 5 minutes to remove bacterial cells. Add an equal amount of 10% trichloroacetic acid to the supernatant, and after 10 minutes, centrifuge at 3,000 rpm for 5 minutes.
The precipitate was collected by centrifugation for 10 minutes, dissolved in IN NaOH, and then subjected to the Lowry method (J, Biol, Chem.
, 193.265 (1951) 3, and the protein amount was converted into bovine serum albumin. The medium shown in Table 1 was selected as a high protein production medium.
これらの5種類の培地のすべての培地に、先に得られた
80株の菌を振盪培養し、いずれかの培地で菌体外蛋白
質を5g72以上生産する菌株を31株−選択した。The 80 strains obtained above were cultured with shaking in all of these five types of media, and 31 strains that produced 5 g or more of extracellular protein in any of the media were selected.
得られた31株について、次に示す、BSAの分解性の
測定及びミルクカゼインの分解性の測定を行った。Regarding the obtained 31 strains, the following measurements of BSA degradability and milk casein degradability were performed.
(BSAの分解性の測定)
T2培地を150mQ用三角フラスコに10+++Ω分
注後オートクレーブ殺菌し、無菌濾過したBSA (S
igmaA4503)溶液を最終濃度3.2mg/mf
lになるように添加し、1晩前培養した菌株を0.21
接種後37℃で20゜rpmにて振盪培養した。(Measurement of degradability of BSA) T2 medium was dispensed into a 150 mQ Erlenmeyer flask at 10++Ω, sterilized in an autoclave, and sterile-filtered BSA (S
igmaA4503) solution to a final concentration of 3.2 mg/mf.
The strain was pre-incubated overnight and the strain was added to a concentration of 0.21 l.
After inoculation, culture was carried out at 37°C with shaking at 20°rpm.
培養24時間、48時間、72時間後にサンプリングし
た培養濾液を10.OOOrpm 5分間遠心分離した
培養上清625 μUに0.5M Tris−C1(p
H6,8)125μQ、10%SDS 200μ2、β
−メルカプトエタノール50μQを添加し攪拌後沸騰水
中で3分間熱処理後0.05%BPBと70%グリセロ
ールを含む0.0625M Tris−CI(pue、
a)の0.1mQを加え5DS−ポリアクリルアミドゲ
ル電気泳動(SO3−PAGE)用の試料としだへスラ
ブ5O3−PAGEは10%のアクリルアミド濃度で行
なった。Culture filtrate sampled after 24 hours, 48 hours, and 72 hours of culture was collected in 10. OOOrpm 0.5M Tris-C1 (p
H6,8) 125μQ, 10% SDS 200μ2, β
- After adding 50 μQ of mercaptoethanol and stirring, heat treated in boiling water for 3 minutes, then 0.0625M Tris-CI (pue,
0.1 mQ of a) was added to prepare a sample for 5DS-polyacrylamide gel electrophoresis (SO3-PAGE).Slab 5O3-PAGE was performed at a 10% acrylamide concentration.
蛋白質の検出はクーマシブリリアントブルーによる染色
により行なった。培養24時間、48時間、72時間す
べてにおいてBSAを分解しなかった菌株を、BSAの
分解性のない菌株とした。Protein detection was performed by staining with Coomassie brilliant blue. A strain that did not degrade BSA during all 24, 48, and 72 hours of culture was designated as a strain that does not have the ability to degrade BSA.
(ミルクカゼインの分解性の測定)
スキムミルク5g、2g、1gを各々50mQ純水に懸
濁した液と寒天1gを純水50mflに溶かした液を別
々にオートクレーブで殺菌機両者を混合後シャーレに分
注して、5%、2%、1%ミルク寒天平板培地を作った
。平板培地に菌株を植苗後37℃にて3日間培養しコロ
ニーの周りが透明になるかどうかamした。5%、2%
、1%ミルク寒天平板培地のすべてに全く透明円をつく
らない菌株をミルクカゼインの分解性のない菌株とした
。(Measurement of degradability of milk casein) A solution in which 5 g, 2 g, and 1 g of skim milk were each suspended in 50 mQ pure water, and a solution in which 1 g agar was dissolved in 50 mfl pure water were mixed separately in an autoclave and sterilized, then separated into petri dishes. 5%, 2%, and 1% milk agar plates were prepared. After planting the bacterial strain on a plate medium, the seedlings were cultured at 37° C. for 3 days, and the surrounding area of the colony was examined to see if it became transparent. 5%, 2%
A strain that did not produce any transparent circles on any of the 1% milk agar plates was designated as a strain that did not have the ability to decompose milk casein.
以上の測定の結果、81402株をBSA及びミルクカ
ゼインをともに分解しないことから、蛋白質分解酵素を
菌体外に生産しない菌株として選定した。As a result of the above measurements, strain 81402 was selected as a strain that does not produce proteolytic enzymes outside the cells, since it does not degrade both BSA and milk casein.
81402株を、Bergey’s Manual D
eterminativeBacteriology
(第8版)及び、The Prokaryote(A
Handbook on Habitats、l5ol
ation andIdentification o
f Bacteria)によって同定したところ、本菌
株は、まず、好気性、ダラム染色陽性、桿菌、胞子を形
成する点においてバチルス属に属するものと認められた
。81402 strain, Bergey's Manual D
eterminative Bacteriology
(8th edition) and The Prokaryote (A
Handbook on Habitats, l5ol
ation and identification o
When the strain was identified by f Bacteria), it was first recognized that it belonged to the genus Bacillus in that it was aerobic, positive for Durham staining, and formed bacilli and spores.
また、その他の、形態的性質、各培地における生育状態
、生理学的性質について、バチルス属の従来知られてい
る菌種と比較検討した結果、バチルスのどの菌種とも異
っていた。また、本菌種には、カゼイン、BSAを分解
する能力もなかった。In addition, as a result of comparing other morphological properties, growth conditions in various media, and physiological properties with conventionally known bacterial species of the genus Bacillus, they were found to be different from any other bacterial species of Bacillus. Furthermore, this bacterial strain did not have the ability to degrade casein and BSA.
従って、本菌種はバチルス属の新菌種として同定された
。Therefore, this bacterial species was identified as a new bacterial species of the genus Bacillus.
かくて、本菌株はバチルス・sp H1402と命名さ
れた。Thus, this bacterial strain was named Bacillus sp H1402.
バチルス・5pH1402はFERM P−8892と
して微工研に寄託されている。Bacillus 5pH1402 has been deposited with the Microtech Institute as FERM P-8892.
次にバチルス・sp H1402の菌学的性質を示す。Next, the mycological properties of Bacillus sp. H1402 will be shown.
(A) 形態的性質
(B) 各培地における生育状態
本発明の菌体外に著量の蛋白質を生産するが、蛋白質分
解酵素を菌体外に生産しない菌株はバチルス・SPP4
O10ある。(A) Morphological properties (B) Growth status in each culture medium The strain of the present invention that produces a significant amount of protein extracellularly but does not produce proteolytic enzymes extracellularly is Bacillus SPP4.
There is O10.
本発明の新規バチルス・sp H1402を培養するこ
とにより著量生産した蛋白質の性質次第では、それ自体
食糧蛋白質やゲル化剤、膨化剤等の食品加工素材または
、ガラス様素材、紙1人工皮革等の表面加工等の工業素
材としての利用等産業上の有用性が非常に高い。Depending on the properties of the protein produced in large quantities by culturing the novel Bacillus sp H1402 of the present invention, it can be used as food protein itself, food processing materials such as gelling agents and swelling agents, glass-like materials, paper, artificial leather, etc. It has very high industrial utility, such as its use as an industrial material for surface finishing.
また、本発明の新規sp H1402を遺伝子組換えの
宿主菌として利用した場合遺伝子組換えによる生産物を
効率良く菌体外に分泌することができ、そして遺伝子組
換えによる生産物を分解することがないので、遺伝子組
換えにおける宿主菌としてきわめてすぐれたものになる
であろう。Furthermore, when the novel sp H1402 of the present invention is used as a host bacterium for genetic recombination, the genetically recombinant product can be efficiently secreted outside the bacterial body, and the genetically recombinant product cannot be degraded. Therefore, it would be an excellent host bacterium for genetic recombination.
この系は、医薬品、良質な食糧蛋白質やゲル化剤、膨化
剤等の食品加工素材、または、ガラス様素材、紙、人工
皮革等の表面加工等の工業素材などの生産手段としての
活用が期待出来る。This system is expected to be used as a means of production for pharmaceuticals, food processing materials such as high-quality food proteins, gelling agents, and leavening agents, and industrial materials such as surface processing of glass-like materials, paper, and artificial leather. I can do it.
以上の様に本発明の有用性は産業上極めて意義深いもの
である。As described above, the usefulness of the present invention is extremely significant industrially.
以下に、実施例を挙げて本発明を更に具体的に説明する
。The present invention will be explained in more detail below by giving Examples.
実施例1
前記第1表記載の5Y培地500mMを2Q容のジャー
ファーメンタ−に分注し、常法により121℃20分滅
菌した後、冷却した。Example 1 500 mM of the 5Y medium listed in Table 1 above was dispensed into a 2Q jar fermentor, sterilized at 121° C. for 20 minutes by a conventional method, and then cooled.
別に、5Y培地5mR分注した試験管をオートクレーブ
することにより滅菌し、これにバチルス・5pH140
2を1白金耳接種し、37℃で14時間振盪培養した。Separately, a test tube containing 5mR of 5Y medium was sterilized by autoclaving, and Bacillus 5pH140 was added to the test tube.
2 was inoculated into one platinum loop, and cultured with shaking at 37°C for 14 hours.
この前培養物5mQをジャーファーメンタ−に接種し、
37℃、48時間、通気量0.5fl/分、回転数40
0rpmで培養した。培養終了後、培養物に等量の0.
2N NaOHを加え攪拌後10000rp+i X
5分遠心分離処理して菌体を除き、上清100+++1
2に等量の10%トリクロル酢酸を加えlO分抜機00
0rpm X 10分間遠心分離して沈澱を集めた。5
%トリクロル酢酸で洗浄し、遠心分離にて沈澱を集めI
N NaOHで溶解した後Lowry法によって定量し
た。蛋白質量は牛血清アルブミンに換算して示した。そ
の結果、菌体外に生産された蛋白質量は5 g/I2で
あった。5 mQ of this preculture was inoculated into a jar fermenter.
37℃, 48 hours, ventilation rate 0.5 fl/min, rotation speed 40
Culture was performed at 0 rpm. After incubation, add an equal amount of 0.
Add 2N NaOH and stir at 10,000 rpm + i
Centrifuge for 5 minutes to remove bacterial cells, and supernatant 100+++1
Add an equal amount of 10% trichloroacetic acid to 2 and use a lO fractionator 00.
The precipitate was collected by centrifugation at 0 rpm for 10 minutes. 5
% trichloroacetic acid and collect the precipitate by centrifugation.
After dissolving with N NaOH, it was quantified by the Lowry method. The amount of protein was expressed in terms of bovine serum albumin. As a result, the amount of protein produced outside the bacterial cells was 5 g/I2.
Claims (1)
菌体外に生産しないバチルス・spH1402。Bacillus spH1402 produces a significant amount of protein extracellularly, but does not produce proteolytic enzymes extracellularly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20515386A JPS6363374A (en) | 1986-09-02 | 1986-09-02 | Novel bacillus sp h1402 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20515386A JPS6363374A (en) | 1986-09-02 | 1986-09-02 | Novel bacillus sp h1402 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6363374A true JPS6363374A (en) | 1988-03-19 |
JPH0586182B2 JPH0586182B2 (en) | 1993-12-10 |
Family
ID=16502295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20515386A Granted JPS6363374A (en) | 1986-09-02 | 1986-09-02 | Novel bacillus sp h1402 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6363374A (en) |
-
1986
- 1986-09-02 JP JP20515386A patent/JPS6363374A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0586182B2 (en) | 1993-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110777136B (en) | Alkaline protease mutant for washing and application thereof in liquid detergent | |
Takagi et al. | Screening and characterization of protein-hyperproducing bacteria without detectable exoprotease activity | |
JPH05252949A (en) | Alkaline protease, its production, its usage and microorganism producing the same protease | |
AU615661B2 (en) | Acid urease and production thereof | |
US4946789A (en) | Bacillus brevis strains and application thereof | |
CN116286565B (en) | Bacillus subtilis strain for high yield of alkaline protease and application thereof | |
LeCorre et al. | Use of a lytic enzyme system from Cytophaga sp. in the lysis of Gram-positive bacteria | |
WO2001016302A1 (en) | Novel thermostable collagen-digesting enzyme, novel microorganism producing the enzyme and process for producing the enzyme | |
JPS6363374A (en) | Novel bacillus sp h1402 | |
JPS60153791A (en) | Bacillus subtilis dsm2704 and production of alpha-amylase using same | |
JPS6363375A (en) | Novel bacillus sp h023 | |
JPS6363376A (en) | Novel bacillus sp h014 | |
JP2882652B2 (en) | Alkaline protease and its producing microorganism | |
JP4380874B2 (en) | Alkaline cellulase gene | |
JP4643873B2 (en) | Heat-resistant laccase and method for producing the same | |
CN117070394B (en) | Alkalophilic strain for producing alkaline protease, alkaline protease and application thereof | |
JPH05211868A (en) | Production of alkali protease | |
JPH07236482A (en) | Alkaline protease, its production and microorganism producing the protease | |
JPH01174378A (en) | Novel microorganism of genus pseudomonas | |
Deviga et al. | Studies on The Optimization of Protease Production by Thermophilic Bacillus subtilis Isolated from Raw Milk Sample | |
JPH01235581A (en) | Novel pseudomonas bacteria | |
RU2684220C1 (en) | Strain clostridium histolyticum - producer of collagenase | |
Bindu et al. | Isolation and identification of a novel strain Bacillus stratosphericus DF producing alkaline protease and optimization of enzyme production | |
JP4752024B2 (en) | Cell wall degrading enzyme, producing microorganism, and protoplast preparation method using the same | |
JPH01235584A (en) | Novel pseudomonas bacteria |